Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.

ABSTRACT:

Background

Neuroendocrine tumours (NETs) can secrete bioactive amines into the bloodstream, causing carcinoid syndrome, with symptoms including flushing and diarrhoea. However, carcinoid syndrome frequency in the NET population has never been rigorously assessed, nor has its relationship to presenting clinicopathological characteristics. This analysis assessed the proportion of patients with NETs and carcinoid syndrome in the USA and associated clinical factors.

Methods

We identified patients (≥65 years of age) from the Surveillance, Epidemiology, and End Results-Medicare database, excluding those with pancreatic tumours or small-cell or large-cell lung cancer, as well as those without complete data. We assessed the incidence of patients with at least two insurance claims of

SUBMITTER: Halperin DM 

PROVIDER: S-EPMC6066284 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature